Apogent Technologies Inc. Announces Acquisition of Chromacol-Epsom Chromatography Group.Business Editors and Health/Medical Writers BIOWIRE2K PORTSMOUTH, N.H.--(BW HealthWire)--Oct. 10, 2001 Apogent Technologies Inc. (NYSE NYSE See: New York Stock Exchange : AOT AOT Agency of Transportation (Vermont, USA) AOT Ahead-of-Time AOT Assisted Outpatient Treatment AOT Aerosol Optical Thickness AOT All of Them (band) AOT As Opposed To AOT Among Other Things ), a leading manufacturer of laboratory and life science consumables and instrumentation, announced today that it acquired the outstanding stock of Chromacol Limited, Epsom Glass Limited and Amchro Inc. (the "Chromacol Group") from United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Filter Corporation and its Protean pro·te·an adj. Readily taking on varied shapes, forms, or meanings. protean changing form or assuming different shapes. subsidiaries. The Chromacol Group manufactures and distributes chromatography vials and related products principally in the European marketplace. The Chromacol Group will be operated under Apogent's National Scientific subsidiary, which currently supplies chromatography vials and related products primarily to the United States market. Epsom Glass Limited manufactures chromatography vials and related products and is Chromacol Limited's principal supplier. Chromacol Limited distributes chromatography vials, inserts and accessories throughout Europe and commands important brand recognition in that marketplace. Chromacol also distributes its products in the United States through Amchro Inc. National Scientific is a significant supplier in the United States of chromatography vials, inserts and accessories, many of which are sourced by National Scientific from third-party manufacturers. The acquisition of the Chromacol Group will enable National Scientific to expand its European customer base, achieve distribution efficiencies in the United States and improve plant and equipment utilization within the acquired companies. Among other things, National Scientific will engage Epsom Glass as a key manufacturer of chromatography vials and related products for National Scientific rather than relying on third-party manufacturers for these items. Craig Jack, President of Apogent's National Scientific subsidiary, stated that "The acquisition of the Chromacol Group will enhance our position in the global chromatography vial market and will generate operating and production efficiencies for National Scientific." Commenting on the Chromacol Group acquisition, Apogent's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Frank H. Jellinek, Jr. said, "The Chromacol Group acquisition creates a positive opportunity to expand in one of our core competency A core competency is something that a firm can do well and that meets the following three conditions specified by Hamel and Prahalad (1990):
National expects to achieve sales revenue of approximately $7.8 million over the next 12 months for the acquired chromatography products. UPCOMING EVENTS Please note that Apogent has rescheduled the release of its fourth fiscal quarter and fiscal year financial results for the period ended September 30, 2001. The release will be after the close of market on Monday, November 12, 2001. Apogent will host a conference call to discuss these results on Tuesday, November 13, 2001 at 11 A.M. EST EST electroshock therapy. EST abbr. electroshock therapy . The dial-in numbers for the teleconference will be: Domestic Callers (800) 582-6982 International Callers (212) 748-2711 The conference call will also be simultaneously audio webcast on Apogent's website in the Investor Relations Investor relations The process by which the corporation communicates with its investors. section at www.apogent.com. An archive of the webcast will be available on Apogent's website until December 14, 2001. On Thursday, October 11, 2001, Apogent management will present at the UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Warburg Global Life Sciences Conference at 10:40 AM EST at The Pierre Hotel in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Listen-only telephone conference lines for public access to Apogent's presentation will be:
Live (800) 500-0177 (Domestic Callers)
(719) 457-2679 (International Callers)
Replay (888) 566-0785 (Domestic Callers)
(402) 220-0102 (International Callers)
On Monday, November 5, 2001, Apogent management will present at The Wall Street Analyst Forum at 1:05 PM EST at The Roosevelt Hotel
On Friday, November 16, 2001, Apogent management will present at the Credit Suisse First Boston Credit Suisse First Boston was originally the trading name of the Financière Crédit Suisse-First Boston, a London-based 50-50 investment banking joint venture formed in 1978 between the First Boston Corporation and Credit Suisse. Healthcare Conference at 8:00 AM MST See micro systems technology. at The Arizona Biltmore in Scottsdale, Arizona Scottsdale (O'odham Vaṣai S-vaṣonĭ) is a city in Maricopa County, Arizona, United States, adjacent to Phoenix. Scottsdale has become internationally recognized as a premier and posh tourist destination, while maintaining its own identity and culture as " . For further information on upcoming investor events, including copies of the written presentation materials from investor conferences, please visit the Investor Relations section of Apogent's website at www.apogent.com BUSINESS DESCRIPTION Apogent Technologies' subsidiaries design, manufacture and market value-added laboratory and life science products for the clinical, research and industrial markets worldwide. The Company's lines of business include Labware and Life Sciences, Diagnostics and Microbiology, Clinical and Industrial, and Laboratory Equipment. Apogent's broad array of industry leading products includes Nalge Nunc International reusable and disposable multi-well plates and plastic labware; Microgenics drug testing products; Applied Biotech rapid diagnostic tests; Erie Scientific coated and printed glass for clinical diagnostics and microarray applications; Richard-Allan Scientific histology histology (hĭstŏl`əjē), study of the groups of specialized cells called tissues that are found in most multicellular plants and animals. and immunohistochemistry consumables and equipment; and Barnstead Thermolyne laboratory equipment and water systems. NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements as defined under Federal securities laws, including statements concerning the Company's strategic and financial goals and market growth. These and other statements that relate to future results and events are based on the Company's current expectations. Actual results in future periods may differ materially from those currently expected or desired because of a number of risks and uncertainties, including the level of demand for the Company's products; currency fluctuations; the intensity of competition; and other factors affecting the Company's business and prospects discussed in the Company's filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-look statement, whether as a result of new information, future events or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion